Matthew Memoli, MD
Enriched profilePrincipal Deputy Director, National Institutes of Health; Acting NIH Director (January 22 - March 31, 2025) · National Institute of Allergy and Infectious Diseases
Matthew Memoli is Principal Deputy Director, National Institutes of Health; Acting NIH Director (January 22 - March 31, 2025) at National Institute of Allergy and Infectious Diseases. OpenAlex indexes 98 publications with 5,145 citations (h-index 38); ClinicalTrials.gov lists 17 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Matthew Memoli, MD, MS, is Principal Deputy Director, National Institutes of Health at National Institute of Allergy and Infectious Diseases. The public record shows 98 publications with 5,145 citations (h-index 38), centered on Influenza Virus Research Studies, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research. It also documents an investigator role on 17 registered clinical trials.
- Most recent indexed publication: 2026 · Personality and individual differences
- Top research focus: Influenza Virus Research Studies
- 17 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 51.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →kvia.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Respiratory Virus Sampling and Repository
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The effect of personality on likelihood of contracting SARS-CoV-2 in the United States.
Personality and individual differences
Article2026 - Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunity.
Science translational medicine
Article2025 - A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.
The Journal of infectious diseases
Article2023 - An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets.
Science translational medicine
Article2022 - Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.
Clinical infectious diseases
Clinical Trial2021
Most-cited works
by citation count (OpenAlex)- 01Bacterial Coinfection in InfluenzaArticle389 citations2013
- 02
- 03IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severityArticle369 citations2017
- 04Proinflammatory IgG Fc structures in patients with severe COVID-19Article324 citations2020
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/matthew-memoli-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- BS
College of William & Mary
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗ - MS
Microbiology, Thomas Jefferson University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗ - MD
St. George's University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Secondary affiliations
appointments beyond the home institution- Chief
Laboratory of Infectious Diseases Clinical Studies Unit, National Institute of Allergy and Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irp.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Michail Lionakis
National Institute of Allergy and Infectious Diseases
Karyl Barron, MD
National Institute of Allergy and Infectious Diseases
Bibiana Bielekova, MD
National Institute of Allergy and Infectious Diseases
Michelle Crank, MD
National Institute of Allergy and Infectious Diseases
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre